286 related articles for article (PubMed ID: 36568145)
1. Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices.
Smita P; Narayan PA; J K; Gaurav P
Front Oncol; 2022; 12():1015200. PubMed ID: 36568145
[TBL] [Abstract][Full Text] [Related]
2. Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics.
Paci A; Veal G; Bardin C; Levêque D; Widmer N; Beijnen J; Astier A; Chatelut E
Eur J Cancer; 2014 Aug; 50(12):2010-9. PubMed ID: 24889915
[TBL] [Abstract][Full Text] [Related]
3. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
4. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
[TBL] [Abstract][Full Text] [Related]
5. Perspectives and Expertise in Establishing a Therapeutic Drug Monitoring Programme for Challenging Childhood Cancer Patient Populations.
Barnett S; Holden V; Campbell-Hewson Q; Veal GJ
Front Oncol; 2021; 11():815040. PubMed ID: 35071019
[TBL] [Abstract][Full Text] [Related]
6. Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs.
Rousseau A; Marquet P
Fundam Clin Pharmacol; 2002 Aug; 16(4):253-62. PubMed ID: 12570013
[TBL] [Abstract][Full Text] [Related]
7. Current status and future outlooks on therapeutic drug monitoring of fluorouracil.
Schmulenson E; Zimmermann N; Mikus G; Joerger M; Jaehde U
Expert Opin Drug Metab Toxicol; 2021 Dec; 17(12):1407-1422. PubMed ID: 35029518
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic monitoring: analytic, pharmacokinetic and clinical aspects].
Marquet P
Acta Clin Belg; 1999; 53 Suppl 1():2-12. PubMed ID: 10216973
[TBL] [Abstract][Full Text] [Related]
9. Precision Oncology by Point-of-Care Therapeutic Drug Monitoring and Dosage Adjustment of Conventional Cytotoxic Chemotherapies: A Perspective.
Briki M; André P; Thoma Y; Widmer N; Wagner AD; Decosterd LA; Buclin T; Guidi M; Carrara S
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111768
[TBL] [Abstract][Full Text] [Related]
10. Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice.
Wilhelm M; Mueller L; Miller MC; Link K; Holdenrieder S; Bertsch T; Kunzmann V; Stoetzer OJ; Suttmann I; Braess J; Birkmann J; Roessler M; Moritz B; Kraff S; Salamone SJ; Jaehde U
Clin Colorectal Cancer; 2016 Dec; 15(4):381-388. PubMed ID: 27256667
[TBL] [Abstract][Full Text] [Related]
11. Utility, promise, and limitations of liquid chromatography-mass spectrometry-based therapeutic drug monitoring in precision medicine.
Gaspar VP; Ibrahim S; Zahedi RP; Borchers CH
J Mass Spectrom; 2021 Nov; 56(11):e4788. PubMed ID: 34738286
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics and therapeutic drug monitoring of anticancer agents].
Marquet P; Rousseau A
Bull Cancer; 2008 Oct; 95(10):903-9. PubMed ID: 19004719
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic drug monitoring of antiretrovirals for people with HIV.
Kredo T; Van der Walt JS; Siegfried N; Cohen K
Cochrane Database Syst Rev; 2009 Jul; (3):CD007268. PubMed ID: 19588422
[TBL] [Abstract][Full Text] [Related]
14. From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for Antibiotics.
Wicha SG; Märtson AG; Nielsen EI; Koch BCP; Friberg LE; Alffenaar JW; Minichmayr IK;
Clin Pharmacol Ther; 2021 Apr; 109(4):928-941. PubMed ID: 33565627
[TBL] [Abstract][Full Text] [Related]
15. 5-Fluorouracil Response Prediction and Blood Level-Guided Therapy in Oncology: Existing Evidence Fundamentally Supports Instigation.
Chavani O
Ther Drug Monit; 2020 Oct; 42(5):660-664. PubMed ID: 32649488
[TBL] [Abstract][Full Text] [Related]
16. Emerging therapeutic drug monitoring technologies: considerations and opportunities in precision medicine.
Liang WS; Beaulieu-Jones B; Smalley S; Snyder M; Goetz LH; Schork NJ
Front Pharmacol; 2024; 15():1348112. PubMed ID: 38545548
[TBL] [Abstract][Full Text] [Related]
17. Concentration-Effect Relationships of Psychoactive Drugs and the Problem to Calculate Therapeutic Reference Ranges.
Hiemke C
Ther Drug Monit; 2019 Apr; 41(2):174-179. PubMed ID: 30883511
[TBL] [Abstract][Full Text] [Related]
18. The role of therapeutic drug monitoring in the management of patients with human immunodeficiency virus infection.
Pretorius E; Klinker H; Rosenkranz B
Ther Drug Monit; 2011 Jun; 33(3):265-74. PubMed ID: 21566505
[TBL] [Abstract][Full Text] [Related]
19. The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With Imatinib.
Buclin T; Thoma Y; Widmer N; André P; Guidi M; Csajka C; Decosterd LA
Front Pharmacol; 2020; 11():177. PubMed ID: 32194413
[TBL] [Abstract][Full Text] [Related]
20. Fluoropyrimidine chemotherapy: recommendations for DPYD genotyping and therapeutic drug monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy.
Hamzic S; Aebi S; Joerger M; Montemurro M; Ansari M; Amstutz U; Largiadèr C
Swiss Med Wkly; 2020 Nov; 150():w20375. PubMed ID: 33232506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
